Le informazioni sugli articoli di fonte ISI sono coperte da copyright

Per ulteriori informazioni selezionare i riferimenti di interesse.

1. Exner, M; Thalhammer-Scherrer, R; Kudlacek, S; Simonitsch, I; Jager, U; Schwarzinger, I
   Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells
   LEUKEMIA & LYMPHOMA
   
   M. Exner et al., "Suspect cell convolutes in the bone marrow of a patient with renal cell carcinoma unmasked as atypical convolutes of hairy cells", LEUK LYMPH, 42(1-2), 2001, pp. 239-241
2. Mitterbauer, M; Neumeister, P; Kalhs, P; Brugger, S; Fischer, C; Dieckmann, K; Hoecker, P; Hinterberger, W; Linkesch, W; Simonitsch, I; Jaeger, U; Lechner, K; Mannhalter, C; Mitterbauer, G; Greinix, HT
   Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma
   LEUKEMIA
   
   M. Mitterbauer et al., "Long-term clinical and molecular remission after allogeneic stem cell transplantation (SCT) in patients with poor prognosis non-Hodgkin's lymphoma", LEUKEMIA, 15(4), 2001, pp. 635-641
3. Speiser, W; Kapiotis, S; Kopp, CW; Simonitsch, I; Jilma, B; Jansen, B; Exner, M; Chott, A
   Effect of intradermal tumor necrosis factor-alpha-induced inflammation on coagulation factors in dermal vessel endothelium - An in vivo study of human skin biopsies
   THROMBOSIS AND HAEMOSTASIS
   
   W. Speiser et al., "Effect of intradermal tumor necrosis factor-alpha-induced inflammation on coagulation factors in dermal vessel endothelium - An in vivo study of human skin biopsies", THROMB HAEM, 85(2), 2001, pp. 362-367
4. Seidemann, K; Tiemann, M; Schrappe, M; Yakisan, E; Simonitsch, I; Janka-Schaub, G; Dorffel, W; Zimmermann, M; Mann, G; Gadner, H; Parwaresch, R; Riehm, H; Reiter, A
   Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90
   BLOOD
   
   K. Seidemann et al., "Short-pulse B-non-Hodgkin lymphoma-type chemotherapy is efficacious treatment for pediatric anaplastic large cell lymphoma: a report of the Berlin-Frankfurt-Munster Group Trial NHL-BFM 90", BLOOD, 97(12), 2001, pp. 3699-3706
5. Filipits, M; Jaeger, U; Simonitsch, I; Chizzali-Bonfadin, C; Heinzl, H; Pirker, R
   Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas
   CLINICAL CANCER RESEARCH
   
   M. Filipits et al., "Clinical relevance of the lung resistance protein in diffuse large B-cell lymphomas", CLIN CANC R, 6(9), 2000, pp. 3417-3423
6. Simonitsch, I; Geusau, A; Chott, A; Jurecka, W
   Cutaneous dendritic cells are main targets in acute HIV-1-infection
   MODERN PATHOLOGY
   
   I. Simonitsch et al., "Cutaneous dendritic cells are main targets in acute HIV-1-infection", MOD PATHOL, 13(11), 2000, pp. 1232-1237
7. Konigsberg, R; Zojer, N; Ackermann, J; Kromer, E; Kittler, H; Fritz, E; Kaufmann, H; Nosslinger, T; Riedl, L; Gisslinger, H; Jager, U; Simonitsch, I; Heinz, R; Ludwig, H; Huber, H; Drach, J
   Predictive role of interphase cytogenetics for survival of patients with multiple myeloma
   JOURNAL OF CLINICAL ONCOLOGY
   
   R. Konigsberg et al., "Predictive role of interphase cytogenetics for survival of patients with multiple myeloma", J CL ONCOL, 18(4), 2000, pp. 804-812
8. Thalhammer-Scherrer, R; Veitl, M; Exner, M; Schneider, B; Geissler, K; Simonitsch, I; Schwarzinger, I
   Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice
   CYTOMETRY
   
   R. Thalhammer-Scherrer et al., "Role of immunological lymphocyte subset typing as a screening method for lymphoid malignancies in daily routine practice", CYTOMETRY, 42(1), 2000, pp. 5-10
9. Klupp, N; Simonitsch, I; Mannhalter, C; Amann, G
   Emergence of an unusual bone marrow precursor B-cell population in fatal Shwachman-Siamond syndrome
   ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE
   
   N. Klupp et al., "Emergence of an unusual bone marrow precursor B-cell population in fatal Shwachman-Siamond syndrome", ARCH PATH L, 124(9), 2000, pp. 1379-1381
10. Locker, GJ; Steger, GG; Gnant, MFX; Steiner, B; Simonitsch, I; Krainer, M; Budinsky, A; Brodowicz, T; Spitzauer, S; Jakesz, R; Zielinski, CC
    Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?
    JOURNAL OF IMMUNOTHERAPY
    
    G.J. Locker et al., "Induction of immunomediated diseases by recombinant human granulocyte-macrophage colony-stimulating factor during cancer treatment?", J IMMUNOTH, 22(1), 1999, pp. 85-89
11. Stohlawetz, P; Schulenburg, A; Stiegler, G; Panzer, S; Hocker, P; Kalhs, P; Schwarzinger, I; Mullauer, L; Simonitsch, I; Geissler, K; Jilma, B
    The proportion of reticulated platelets is higher in bone marrow than in peripheral blood in haematological patients
    EUROPEAN JOURNAL OF HAEMATOLOGY
    
    P. Stohlawetz et al., "The proportion of reticulated platelets is higher in bone marrow than in peripheral blood in haematological patients", EUR J HAEMA, 63(4), 1999, pp. 239-244
12. Thalhammer-Scherrer, R; Wieselthaler, G; Knoebl, P; Schwarzinger, I; Simonitsch, I; Mitterbauer, G; Berlakovich, GA; Mannhalter, C; Haas, OA; Mayer, G; Muehlbacher, F; Wolner, E; Klepetko, W; Lechner, K; Jaeger, U
    Post-transplant acute myeloid leukemia (PT-AML)
    LEUKEMIA
    
    R. Thalhammer-Scherrer et al., "Post-transplant acute myeloid leukemia (PT-AML)", LEUKEMIA, 13(3), 1999, pp. 321-326
13. Berer, A; Ohler, L; Simonitsch, I; Thalhammer, R; Lechner, K; Geissler, K
    Long term improvement of hematopoiesis following cyclosporine treatment ina patient with myelodysplastic syndrome
    WIENER KLINISCHE WOCHENSCHRIFT
    
    A. Berer et al., "Long term improvement of hematopoiesis following cyclosporine treatment ina patient with myelodysplastic syndrome", WIEN KLIN W, 111(19), 1999, pp. 815-818
14. Sillaber, C; Walchshofer, S; Mosberger, I; Gaiger, A; Simonitsch, I; Chott, A; Lechner, K; Valent, P
    Immunophenotypic characterization of human bone marrow endosteal cells
    TISSUE ANTIGENS
    
    C. Sillaber et al., "Immunophenotypic characterization of human bone marrow endosteal cells", TISSUE ANTI, 53(6), 1999, pp. 559-568
15. Chott, A; Vesely, M; Simonitsch, I; Mosberger, I; Hanak, H
    Classification of intestinal T-cell neoplasms and their differential diagnosis
    AJCP. American journal of clinical pathology
    
    A. Chott et al., "Classification of intestinal T-cell neoplasms and their differential diagnosis", AM J CLIN P, 111(1), 1999, pp. S68-S74
16. KRUPITZA G; GRUSCH M; BRAUN K; FUHRMANN G; STEINBRUGGER R; HULLA W; SIMONITSCH I; CHOTT A; HENGSTSCHLAGER M
    TNF-ALPHA-MEDIATED CELL-DEATH IS INDEPENDENT OF CDC25A
    Cell death and differentiation
    
    G. Krupitza et al., "TNF-ALPHA-MEDIATED CELL-DEATH IS INDEPENDENT OF CDC25A", Cell death and differentiation, 5(9), 1998, pp. 758-764
17. HAGEN W; SCHWARZMEIER J; WALCHSHOFER S; ZOJER N; CHOTT A; SILLABER C; ACKERMANN J; SIMONITSCH I; BUHRING HJ; DRACH J; LECHNER K; HORNY HP; VALENT P
    A CASE OF BONE-MARROW MASTOCYTOSIS ASSOCIATED WITH MULTIPLE-MYELOMA
    Annals of hematology
    
    W. Hagen et al., "A CASE OF BONE-MARROW MASTOCYTOSIS ASSOCIATED WITH MULTIPLE-MYELOMA", Annals of hematology, 76(3-4), 1998, pp. 167-174
18. CHOTT A; VESELY M; SIMONITSCH I; MOSBERGER I; HANAK H
    INTESTINAL T-CELL LYMPHOMA (ITL) CLASSIFICATION PROPOSAL BASED ON 44 CASES
    Modern pathology
    
    A. Chott et al., "INTESTINAL T-CELL LYMPHOMA (ITL) CLASSIFICATION PROPOSAL BASED ON 44 CASES", Modern pathology, 11(1), 1998, pp. 127-127
19. SILLABER C; WALCHSHOFER S; MOSBERGER I; SIMONITSCH I; CHOTT A; VALENT K
    THE PHENOTYPE OF BONE-MARROW ENDOSTEAL CELLS
    Modern pathology
    
    C. Sillaber et al., "THE PHENOTYPE OF BONE-MARROW ENDOSTEAL CELLS", Modern pathology, 11(1), 1998, pp. 140-140
20. Sperr, WR; Walchshofer, S; Horny, HP; Fodinger, M; Simonitsch, I; Fritsche-Polanz, R; Schwarzinger, I; Tschachler, E; Sillaber, C; Hagen, W; Geissler, K; Chott, A; Lechner, K; Valent, P
    Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val
    BRITISH JOURNAL OF HAEMATOLOGY
    
    W.R. Sperr et al., "Systemic mastocytosis associated with acute myeloid leukaemia: report of two cases and detection of the c-kit mutation Asp-816 to Val", BR J HAEM, 103(3), 1998, pp. 740-749
21. Strohal, R; Tschachler, E; Breyer, S; Uthman, A; Simonitsch, I; Tratting, S; Scheithauer, W; Stingl, G; Kornek, GV
    Reactivation of Behcet's disease in the course of multicentric HHV8-positive Castleman's disease: Long-term complete remission by a combined chemo/radiation and interferon-alpha therapy regimen
    BRITISH JOURNAL OF HAEMATOLOGY
    
    R. Strohal et al., "Reactivation of Behcet's disease in the course of multicentric HHV8-positive Castleman's disease: Long-term complete remission by a combined chemo/radiation and interferon-alpha therapy regimen", BR J HAEM, 103(3), 1998, pp. 788-790
22. SIMONITSCH I; KRUPITZA G
    AUTOCRINE SELF-ELIMINATION OF CULTURED OVARIAN-CANCER CELLS BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA)
    British Journal of Cancer
    
    I. Simonitsch e G. Krupitza, "AUTOCRINE SELF-ELIMINATION OF CULTURED OVARIAN-CANCER CELLS BY TUMOR-NECROSIS-FACTOR-ALPHA (TNF-ALPHA)", British Journal of Cancer, 78(7), 1998, pp. 862-870
23. FUHRMANN G; GRUSCH M; HULLA W; SIMONITSCH I; CHOTT A; KRUPITZA G
    APOPTOSIS OF OVARIAN-CARCINOMA CELLS (N1) BY TNF AND ITS POSSIBLE TARGETS
    European journal of cancer
    
    G. Fuhrmann et al., "APOPTOSIS OF OVARIAN-CARCINOMA CELLS (N1) BY TNF AND ITS POSSIBLE TARGETS", European journal of cancer, 33, 1997, pp. 79-79
24. FRIDRIK MA; GREIL R; HAUSMANINGER H; KRIEGER O; OPPITZ P; STOGER M; KLOCKER J; NEUBAUER M; HELM W; PONT J; FAZENY B; HUDEC M; SIMONITSCH I; RADASZKIEWICZ T
    RANDOMIZED OPEN-LABEL PHASE-III TRIAL OF CEOP IMVP-DEXA ALTERNATING CHEMOTHERAPY AND FILGRASTIM VERSUS CEOP/IMVP-DEXA ALTERNATING CHEMOTHERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - A MULTICENTER TRIAL BY THE AUSTRIAN WORKING GROUP FOR MEDICAL TUMOR-THERAPY/
    Annals of hematology
    
    M.A. Fridrik et al., "RANDOMIZED OPEN-LABEL PHASE-III TRIAL OF CEOP IMVP-DEXA ALTERNATING CHEMOTHERAPY AND FILGRASTIM VERSUS CEOP/IMVP-DEXA ALTERNATING CHEMOTHERAPY FOR AGGRESSIVE NON-HODGKINS-LYMPHOMA (NHL) - A MULTICENTER TRIAL BY THE AUSTRIAN WORKING GROUP FOR MEDICAL TUMOR-THERAPY/", Annals of hematology, 75(4), 1997, pp. 135-140
25. WANSCHITZ J; HAINFELLNER JA; SIMONITSCH I; SCHNIZER M; DEISENHAMMER E; TERUNUMA H; IWASAKI Y; BUDKA H
    NON-HTLV-I ASSOCIATED PLEOMORPHIC T-CELL LYMPHOMA OF THE BRAIN MIMICKING POST-VACCINAL ACUTE INFLAMMATORY DEMYELINATION
    Neuropathology and applied neurobiology
    
    J. Wanschitz et al., "NON-HTLV-I ASSOCIATED PLEOMORPHIC T-CELL LYMPHOMA OF THE BRAIN MIMICKING POST-VACCINAL ACUTE INFLAMMATORY DEMYELINATION", Neuropathology and applied neurobiology, 23(1), 1997, pp. 43-49
26. SPERR WR; WALCHSHOFER S; HORNY HP; FODINGER M; CHOTT A; SIMONITSCH I; SILLABER C; SCHWARZINGER I; TSCHACHLER E; GEISSLER K; LECHNER K; VALENT P
    DETECTION OF THE C-KIT POINT MUTATION ASP-]VAL-[816] IN SYSTEMIC MASTOCYTOSIS ASSOCIATED WITH AML
    Blood
    
    W.R. Sperr et al., "DETECTION OF THE C-KIT POINT MUTATION ASP-]VAL-[816] IN SYSTEMIC MASTOCYTOSIS ASSOCIATED WITH AML", Blood, 90(10), 1997, pp. 3739-3739
27. SIMONITSCH I; KOPP CW; MOSBERGER I; VOLCPLATZER B; RADASZKIEWICZ T
    EXPRESSION OF THE MONOCLONAL-ANTIBODY HECA-452 DEFINED E-SELECTIN LIGANDS IN LANGERHANS CELL HISTIOCYTOSIS
    Virchows Archiv
    
    I. Simonitsch et al., "EXPRESSION OF THE MONOCLONAL-ANTIBODY HECA-452 DEFINED E-SELECTIN LIGANDS IN LANGERHANS CELL HISTIOCYTOSIS", Virchows Archiv, 427(5), 1996, pp. 477-481
28. MITTERBAUER M; FRITZERSZEKERES M; MITTERBAUER G; SIMONITSCH I; KNOBL P; RINTELEN C; SCHWARZINGER I; HAAS OA; SILBERBAUER K; FREY K; BIBUS B; PABINGER I; RADASZKIEWICZ T; LECHNER K; JAEGER U
    SPONTANEOUS REMISSION OF ACUTE MYELOID-LEUKEMIA AFTER INFECTION AND BLOOD-TRANSFUSION ASSOCIATED WITH HYPERGAMMAGLOBULINEMIA
    Annals of hematology
    
    M. Mitterbauer et al., "SPONTANEOUS REMISSION OF ACUTE MYELOID-LEUKEMIA AFTER INFECTION AND BLOOD-TRANSFUSION ASSOCIATED WITH HYPERGAMMAGLOBULINEMIA", Annals of hematology, 73(4), 1996, pp. 189-193
29. FODINGER M; BUCHMAYER H; SCHWARZINGER I; SIMONITSCH I; WINKLER K; JAGER U; KNOBLER R; MANNHALTER C
    MULTIPLEX PCR FOR RAPID DETECTION OF T-CELL RECEPTOR-GAMMA CHAIN GENEREARRANGEMENTS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES
    British Journal of Haematology
    
    M. Fodinger et al., "MULTIPLEX PCR FOR RAPID DETECTION OF T-CELL RECEPTOR-GAMMA CHAIN GENEREARRANGEMENTS IN PATIENTS WITH LYMPHOPROLIFERATIVE DISEASES", British Journal of Haematology, 94(1), 1996, pp. 136-139
30. SIMONITSCH I; PANZERGRUEMAYER ER; GHALI DW; ZOUBEK A; RADASZKIEWICZ T; GADNER H; KOVAR H
    NPM ALK GENE FUSION TRANSCRIPTS IDENTIFY A DISTINCT SUBGROUP OF NULL TYPE KI-1 POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMAS/
    British Journal of Haematology
    
    I. Simonitsch et al., "NPM ALK GENE FUSION TRANSCRIPTS IDENTIFY A DISTINCT SUBGROUP OF NULL TYPE KI-1 POSITIVE ANAPLASTIC LARGE-CELL LYMPHOMAS/", British Journal of Haematology, 92(4), 1996, pp. 866-871
31. ARYEE DNT; SIMONITSCH I; MOSBERGER I; KOS K; MANN G; SCHLOGL E; POTSCHGER U; GADNER H; RADASZKIEWICZ T; KOVAR H
    VARIABILITY OF NM23-H1 NDPK-A EXPRESSION IN HUMAN LYMPHOMAS AND ITS RELATION TO TUMOR AGGRESSIVENESS/
    British Journal of Cancer
    
    D.N.T. Aryee et al., "VARIABILITY OF NM23-H1 NDPK-A EXPRESSION IN HUMAN LYMPHOMAS AND ITS RELATION TO TUMOR AGGRESSIVENESS/", British Journal of Cancer, 74(11), 1996, pp. 1693-1698
32. WALCHSHOFER S; BAGHESTANIAN M; GAIGER A; KNOBL P; MOSBERGER I; SIMONITSCH I; CHOTT A; LECHNER K; VALENT P; SILLABER C
    ANTIGENIC CHARACTERIZATION OF HUMAN BONE-MARROW ENDOSTEAL CELLS - A STEM-CELL HYPOTHESIS REANALYZED
    Blood
    
    S. Walchshofer et al., "ANTIGENIC CHARACTERIZATION OF HUMAN BONE-MARROW ENDOSTEAL CELLS - A STEM-CELL HYPOTHESIS REANALYZED", Blood, 88(10), 1996, pp. 3249-3249
33. DELLEKARTH G; LACZIKA K; SCHOLTEN C; LECHNER K; JAEGER U; SCHWARZINGER I; SIMONITSCH I
    CLEARANCE OF PCR-DETECTABLE LYMPHOMA-CELLS FROM THE PERIPHERAL-BLOOD,BUT NOT BONE-MARROW AFTER THERAPY WITH CAMPATH-1H
    American journal of hematology
    
    G. Dellekarth et al., "CLEARANCE OF PCR-DETECTABLE LYMPHOMA-CELLS FROM THE PERIPHERAL-BLOOD,BUT NOT BONE-MARROW AFTER THERAPY WITH CAMPATH-1H", American journal of hematology, 50(2), 1995, pp. 146-147
34. KOELLER M; KIENER H; SIMONITSCH I; ARINGER M; STEINER CW; MACHOLD K; GRANINGER W
    DESTRUCTIVE LYMPHADENOPATHY AND T-LYMPHOCYTE ACTIVATION IN ADULT-ONSET STILLS DISEASE
    British journal of rheumatology
    
    M. Koeller et al., "DESTRUCTIVE LYMPHADENOPATHY AND T-LYMPHOCYTE ACTIVATION IN ADULT-ONSET STILLS DISEASE", British journal of rheumatology, 34(10), 1995, pp. 984-988
35. LOCKER GJ; SIMONITSCH I; MADER RM; WARLAMIDES E; GNANT MFX; JAKESZ R; RAINER H; STEGER GG
    CUTANEOUS SIDE-EFFECTS IN BREAST-CANCER PATIENTS TREATED WITH CYTOSTATIC POLYCHEMOTHERAPY AND RH GM-CSF - IMMUNE PHENOMENA OR DRUG TOXICITY
    Breast cancer research and treatment
    
    G.J. Locker et al., "CUTANEOUS SIDE-EFFECTS IN BREAST-CANCER PATIENTS TREATED WITH CYTOSTATIC POLYCHEMOTHERAPY AND RH GM-CSF - IMMUNE PHENOMENA OR DRUG TOXICITY", Breast cancer research and treatment, 34(3), 1995, pp. 213-219
36. ZOUBEK A; SIMONITSCH I; PANZERGRUMAYER ER; GHALI D; PFLEIDERER C; HAAS OA; MANN G; LANG S; RADASZKIEWICZ T; GADNER H; KOVAR H
    EWING TUMOR AFTER TREATMENT OF KI-1(-CELL LYMPHOMA - THERAPY-ASSOCIATED SECONDARY NEOPLASM OR UNRELATED COINCIDENCE() ANAPLASTIC LARGE)
    Cancer genetics and cytogenetics
    
    A. Zoubek et al., "EWING TUMOR AFTER TREATMENT OF KI-1(-CELL LYMPHOMA - THERAPY-ASSOCIATED SECONDARY NEOPLASM OR UNRELATED COINCIDENCE() ANAPLASTIC LARGE)", Cancer genetics and cytogenetics, 83(1), 1995, pp. 5-11
37. THALHAMMER F; GISSLINGER H; CHOTT A; HAAS O; ETELEHAINZ A; HELBICH T; KUSEC R; LINKESCH W; SIMONITSCH I; STROBL H; LECHNER K; JAGER U
    GRANULOCYTIC SARCOMA OF THE PROSTATE AS THE 1ST MANIFESTATION OF A LATE RELAPSE OF ACUTE MYELOGENOUS LEUKEMIA
    Annals of hematology
    
    F. Thalhammer et al., "GRANULOCYTIC SARCOMA OF THE PROSTATE AS THE 1ST MANIFESTATION OF A LATE RELAPSE OF ACUTE MYELOGENOUS LEUKEMIA", Annals of hematology, 68(2), 1994, pp. 97-99
38. PIRCDANOEWINATA H; CHOTT A; ONDERKA E; DRACH J; SCHLOGL E; JAGER U; THALHAMMER F; NOWOTNY H; ARYEE D; STEGER GG; LOCKER G; MICHL I; DJAVANMARD M; SIMONITSCH I; RADASZKIEWICZ T; HANAK H; SCHNEIDER B; HEINZ R; MAROSI C
    KARYOTYPE AND PROGNOSIS IN NON-HODGKIN-LYMPHOMA
    Leukemia
    
    H. Pircdanoewinata et al., "KARYOTYPE AND PROGNOSIS IN NON-HODGKIN-LYMPHOMA", Leukemia, 8(11), 1994, pp. 1929-1939
39. SIMONITSCH I; VOLCPLATZER B; MOSBERGER I; RADASZKIEWICZ T
    EXPRESSION OF BETA-7 INTEGRIN DEFINING MONOCLONAL-ANTIBODY HML-1 IN CUTANEOUS T-CELL LYMPHOMAS
    Laboratory investigation
    
    I. Simonitsch et al., "EXPRESSION OF BETA-7 INTEGRIN DEFINING MONOCLONAL-ANTIBODY HML-1 IN CUTANEOUS T-CELL LYMPHOMAS", Laboratory investigation, 70(1), 1994, pp. 10000121-10000121
40. KOSZIK F; STRUNK D; SIMONITSCH I; PICKER LJ; STINGL G; PAYER E
    EXPRESSION OF MONOCLONAL-ANTIBODY HECA-452-DEFINED E-SELECTIN LIGANDSON LANGERHANS CELLS IN NORMAL AND DISEASED SKIN
    Journal of investigative dermatology
    
    F. Koszik et al., "EXPRESSION OF MONOCLONAL-ANTIBODY HECA-452-DEFINED E-SELECTIN LIGANDSON LANGERHANS CELLS IN NORMAL AND DISEASED SKIN", Journal of investigative dermatology, 102(5), 1994, pp. 773-780
41. SIMONITSCH I; VOLCPLATZER B; MOSBERGER I; RADASZKIEWICZ T
    EXPRESSION OF MONOCLONAL-ANTIBODY HML-1-DEFINED ALPHA(E)BETA-7 INTEGRIN IN CUTANEOUS T-CELL LYMPHOMA
    The American journal of pathology
    
    I. Simonitsch et al., "EXPRESSION OF MONOCLONAL-ANTIBODY HML-1-DEFINED ALPHA(E)BETA-7 INTEGRIN IN CUTANEOUS T-CELL LYMPHOMA", The American journal of pathology, 145(5), 1994, pp. 1148-1158